Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Explore clinical trials studying Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative. Study availability and eligibility vary by location and protocol.

154 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative trial results

Completed

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

NCT00045305

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Tufts-NEMC Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details
Completed

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

NCT00897767

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 214 locations
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

NCT02092324

Conditions
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details

Related conditions